Discovery of novel DAPY-IAS hybrid derivatives as potential HIV-1 inhibitors using molecular hybridization based on crystallographic overlays

Boshi Huang; Xueshun Wang; Xinhao Liu; Zihui Chen; Wanzhuo Li; Songkai Sun; Huiqing Liu; Dirk Daelemans; De Clercq Erik; Christophe Pannecouque; Peng Zhan; Xinyong Liu

doi:10.1016/j.bmc.2017.06.022

Back

Discovery of novel DAPY-IAS hybrid derivatives as potential HIV-1 inhibitors using molecular hybridization based on crystallographic overlays

Article 2017 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2014

Discovery of 2-pyridone derivatives as potent HIV-1 NNRTIs using molecular hybridization based on crystallographic overlays

Wen‐Ming Chen, Peng Zhan, Diwakar Rai, De Clercq Erik, Christophe Pannecouque, Jan Balzarini, Zhongxia Zhou, Huiqing Liu, Xinyong Liu

Article2017

Discovery of uracil-bearing DAPYs derivatives as novel HIV-1 NNRTIs via crystallographic overlay-based molecular hybridization

Heng Zhang, Ye Tian, Dongwei Kang, Zhipeng Huo, Zhongxia Zhou, Huiqing Liu, De Clercq Erik, Christophe Pannecouque, Peng Zhan, Xinyong Liu

Article2013

Molecular design, synthesis and biological evaluation of BP-O-DAPY and O-DAPY derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors

Shiqiong Yang, Christophe Pannecouque, Dirk Daelemans, Xiaodong Ma, Yang Liu, Fen‐Er Chen, De Clercq Erik

Article2022

Disubstituted pyrimidine-5-carboxamide derivatives as novel HIV-1 NNRTIs: Crystallographic overlay-based molecular design, synthesis, and biological evaluation

Da Feng, Hao Lin, Liyang Jiang, Jiaojiao Dai, Xiaoying Zhang, Zhongxia Zhou, Yanying Sun, Zhao Wang, De Clercq Erik, Christophe Pannecouque, Dongwei Kang, Peng Zhan, Xinyong Liu

Article2012

Synthesis and Anti-HIV Evaluation of Novel 1,2,4-triazole Derivatives as Potential Non-nucleoside HIV-1 Reverse Transcriptase Inhibitors

Zhenyu Li, Yuan Cao, Peng Zhan, Christophe Pannecouque, Jan Balzarini, De Clercq Erik, Xinyong Liu